Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Clinical Trial

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jul 12, 2023 3:33pm

250 Views

Post# 35537999

RE:RE:RE:RE:RE:RE: RE: Clinical Trial

Well, that is a good point. We only have another ~40 or so to treat for the trial, maybe pay for those, or would insurance cover? But anyone else that wanted 1433 for NMIBC or something off label like melanoma, could pay or get thier insurance company to..?? IMO. I think they sigaled it would be expensive.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing